As the melting continues to TRANSGRESSIONS To kill the united CEO Brian Johnson, a billionaire backing the big companies who believe the job increases.

Mr. Michael Spencer, the billionaire finance in Britain, was disappointed in his faith that CEOs in the UK should be paid to the same ballpark like pre premier league’s Kevin de Brunelne and Mistaken Haaland.

“We don’t mind paying our footballers, top-rate footballers, unique amounts of money,” Spencer told the Permanda.

“Whatever is considered to be fully acceptable. But if the CEO of BP or HSBC gets £ 20 million a year, everything is less than saying it is an anger.”

He added: “The US celebrates the fact that many chief executives earn a lot of money. They want their chief executives to be paid like football stars.”

Spencer’s argument is similar to the one made by Ryanair CEO Michael O’Leary in Abra, who used footballer fees to reasonably His potential € 100 million bonuses.

The problem with Spencer’s comments? CEOs are effectively paid like UK players

The multi-millionaire CEOs is the norm

The average fteds 100 CEO gets £ 4.2 million in 2023, while Permanda Analysis shows the average salary at the Premier League is £ 1.98 million in the same year.

Spencer is likely to suggest that CEOs should be paid for levels similar to the highest Premier League fees. But even here, numbers are compared.

Kevin City de Brugenne is thought to be the highest paid player, who earns salary about £ 400,000 per week, or £ 20.8 million a year. With relevant playback bonuses and sponsorship deals, he or she is likely to be millions.

AstraZeneca CEO Pascal Soriot has taken £ 16.85 million in 2023, which makes him a maximum fee boss in FTSE 100. In the second place Erik Erginbilic, while Rolls Royce Erginbilic took £ 13.61 million.

UK bosses face swift resistance from investors to pay recent years. Astrazeneca’s sorarize saw 38.5% of shareholders declined plans for a £ 1.8 million increase in April payment.

Rajiv Jain, the Chief Investment Officer of the top 20 shareholder GQG colleagues, said Soriot “is widely free” compared to US pharmaceutical CEOs.

Shareholders take care of the bumper pay approval to rise in a history of history history to hit harder.

On the other hand, paid fee supporters say that they should resist a flying company and talent from UK companies in the UK in the US to find better valuation in the market.

C-suite of spotlight

Spencer’s comments arrive at a time of deep riot in the C-suite.

Killing the united CEO by Brian Thompson last week was carried out by the Spotlight Executive Executive securely with major companies.

Fitchhealthecare and other insurance companies, health health and song blue blue shields, Took the board leadership bios In an apparent effort to protect their privacy amongst your raised safety concerns.

Fortune’s Ruth editor Umoh and Reporter Natalie McCormick wrote a Trepidation trend growth Among the execs to transfer to the office of the corner, one that can be rapidly in Johnson’s death.

Those who are hoping to reverse a higher salary can be way of going.

This story originally shown Fortune.com

Source link